Furthermore, we could measure a higher binding of eIF4A1 to NFKBIA mRNA in CLL than in healthy-donor PBMCs, using an RNA immunoprecipitation assay (RIP) (Figure 2D). The gene discussed is EIF4A1; the disease is B-cell chronic lymphocytic leukemia.